Cargando…

The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice

The therapy of depression is challenging and still unsatisfactory despite the presence of many antidepressant drugs on the market. Consequently, there is a continuous need to search for new, safer, and more effective antidepressant therapeutics. Previous studies have suggested a potential associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatachalam, Karthikkumar, Zhong, Sicheng, Dubiel, Mariam, Satała, Grzegorz, Sadek, Bassem, Stark, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138994/
https://www.ncbi.nlm.nih.gov/pubmed/35625611
http://dx.doi.org/10.3390/biom12050683
_version_ 1784714755802398720
author Venkatachalam, Karthikkumar
Zhong, Sicheng
Dubiel, Mariam
Satała, Grzegorz
Sadek, Bassem
Stark, Holger
author_facet Venkatachalam, Karthikkumar
Zhong, Sicheng
Dubiel, Mariam
Satała, Grzegorz
Sadek, Bassem
Stark, Holger
author_sort Venkatachalam, Karthikkumar
collection PubMed
description The therapy of depression is challenging and still unsatisfactory despite the presence of many antidepressant drugs on the market. Consequently, there is a continuous need to search for new, safer, and more effective antidepressant therapeutics. Previous studies have suggested a potential association of brain histaminergic/serotoninergic signaling and antidepressant- and anxiolytic-like effects. Here, we evaluated the in vivo antidepressant- and anxiolytic-like effects of the newly developed multiple-active ligand ST-2300. ST-2300 was developed from 5-HT(2A/2C) inverse agonist pimavanserin (PIM, ACP-103) and incorporates a histamine H(3) receptor (H(3)R) antagonist pharmacophore. Despite its parent compound, ST-2300 showed only moderate serotonin 5-HT(2A) antagonist/inverse agonist affinity (K(i) value of 1302 nM), but excellent H(3)R affinity (K(i) value of 14 nM). In vivo effects were examined using forced swim test (FST), tail suspension test (TST), and the open field test (OFT) in C57BL/6 mice. Unlike PIM, ST-2300 significantly increased the anxiolytic-like effects in OFT without altering general motor activity. In FST and TST, ST-2300 was able to reduce immobility time similar to fluoxetine (FLX), a recognized antidepressant drug. Importantly, pretreatment with the CNS-penetrant H(3)R agonist (R)-α-methylhistamine reversed the antidepressant-like effects of ST-2300 in FST and TST, but failed to reverse the ST-2300-provided anxiolytic effects in OFT. Present findings reveal critical structural features that are useful in a rational multiple-pharmacological approach to target H(3)R/5-HT(2A)/5-HT(2C).
format Online
Article
Text
id pubmed-9138994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91389942022-05-28 The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice Venkatachalam, Karthikkumar Zhong, Sicheng Dubiel, Mariam Satała, Grzegorz Sadek, Bassem Stark, Holger Biomolecules Article The therapy of depression is challenging and still unsatisfactory despite the presence of many antidepressant drugs on the market. Consequently, there is a continuous need to search for new, safer, and more effective antidepressant therapeutics. Previous studies have suggested a potential association of brain histaminergic/serotoninergic signaling and antidepressant- and anxiolytic-like effects. Here, we evaluated the in vivo antidepressant- and anxiolytic-like effects of the newly developed multiple-active ligand ST-2300. ST-2300 was developed from 5-HT(2A/2C) inverse agonist pimavanserin (PIM, ACP-103) and incorporates a histamine H(3) receptor (H(3)R) antagonist pharmacophore. Despite its parent compound, ST-2300 showed only moderate serotonin 5-HT(2A) antagonist/inverse agonist affinity (K(i) value of 1302 nM), but excellent H(3)R affinity (K(i) value of 14 nM). In vivo effects were examined using forced swim test (FST), tail suspension test (TST), and the open field test (OFT) in C57BL/6 mice. Unlike PIM, ST-2300 significantly increased the anxiolytic-like effects in OFT without altering general motor activity. In FST and TST, ST-2300 was able to reduce immobility time similar to fluoxetine (FLX), a recognized antidepressant drug. Importantly, pretreatment with the CNS-penetrant H(3)R agonist (R)-α-methylhistamine reversed the antidepressant-like effects of ST-2300 in FST and TST, but failed to reverse the ST-2300-provided anxiolytic effects in OFT. Present findings reveal critical structural features that are useful in a rational multiple-pharmacological approach to target H(3)R/5-HT(2A)/5-HT(2C). MDPI 2022-05-10 /pmc/articles/PMC9138994/ /pubmed/35625611 http://dx.doi.org/10.3390/biom12050683 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Venkatachalam, Karthikkumar
Zhong, Sicheng
Dubiel, Mariam
Satała, Grzegorz
Sadek, Bassem
Stark, Holger
The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice
title The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice
title_full The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice
title_fullStr The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice
title_full_unstemmed The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice
title_short The Novel Pimavanserin Derivative ST-2300 with Histamine H(3) Receptor Affinity Shows Reduced 5-HT(2A) Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice
title_sort novel pimavanserin derivative st-2300 with histamine h(3) receptor affinity shows reduced 5-ht(2a) binding, but maintains antidepressant- and anxiolytic-like properties in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138994/
https://www.ncbi.nlm.nih.gov/pubmed/35625611
http://dx.doi.org/10.3390/biom12050683
work_keys_str_mv AT venkatachalamkarthikkumar thenovelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT zhongsicheng thenovelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT dubielmariam thenovelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT satałagrzegorz thenovelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT sadekbassem thenovelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT starkholger thenovelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT venkatachalamkarthikkumar novelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT zhongsicheng novelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT dubielmariam novelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT satałagrzegorz novelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT sadekbassem novelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice
AT starkholger novelpimavanserinderivativest2300withhistamineh3receptoraffinityshowsreduced5ht2abindingbutmaintainsantidepressantandanxiolyticlikepropertiesinmice